Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Divya Avula"'
Autor:
Mona T Yazdi, Divya Avula
Publikováno v:
Open Forum Infectious Diseases. 9
Background Per 2010 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer, routine use of fluoroquinolone (FQ) chemoprophylaxis in low-risk populations (defin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f03c177e3f0908bd26c3f2345a80eb3
https://doi.org/10.1093/ofid/ofac492.1403
https://doi.org/10.1093/ofid/ofac492.1403
Autor:
Susan A. Smith, Divya Avula, Jaimin R. Trivedi, Joseph C Sweeney, Mark S. Slaughter, Brian L. Ganzel
Publikováno v:
Journal of Cardiac Surgery. 36:4038-4042
Stentless porcine bioprothesis is a surgical strategy to treat aortic root disease. Use has been limited due to the concern for long-term valve degeneration. This study evaluated the perioperative and late outcomes of patients with aortic root diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f2f1d006cfd6c0023076469126ccde
https://doi.org/10.1111/jocs.15910
https://doi.org/10.1111/jocs.15910
Autor:
Mary Arakelyan, Seneca Freyleue, Divya Avula, Jennifer L. McLaren, A. James O’Malley, JoAnna K. Leyenaar
Publikováno v:
JAMA. 329:1000
ImportanceApproximately 1 in 6 youth in the US have a mental health condition, and suicide is a leading cause of death among this population. Recent national statistics describing acute care hospitalizations for mental health conditions are lacking.O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c320ecaaf2dbf3ef89388edcc9e54d
https://doi.org/10.1001/jama.2023.1992
https://doi.org/10.1001/jama.2023.1992
Autor:
Katherine R. Whitehouse, Divya Avula, Tanvir Kahlon, Devan Costelle, Christina Dunbar-Matos, Siddharth Pahwa, Jaimin R. Trivedi, Mark S. Slaughter
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(3)
Patients with left ventricular assist devices currently require long-term anticoagulation with warfarin. Warfarin requires frequent blood tests and is associated with adverse events when not in the therapeutic range. Apixaban is a possible alternativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4872f2bf92277efe1efec364081b9e7c
https://pubmed.ncbi.nlm.nih.gov/35213880
https://pubmed.ncbi.nlm.nih.gov/35213880